A Change For Generics And Biosimilars Is On The Horizon
Sponsored by:
With the pharmaceutical industry still adjusting to the potential impacts of Humira's loss of exclusivity, another milestone for biosimilars has been achieved in 2022.
Keep up with the top pharma business news of the week. On the go.
Sponsored by: